Latest

FDA

diversity in clinical trials, people in a line

The Side Effects of Inequality: How Lack of Diversity in Clinical Trials Affects Drug Effectiveness and Safety

Daphne Berryhill

FDA SIDE EFFECTS UPDATE: Zepbound for Obstructive Sleep Apnea, Ibrance And Blood Clots, Plus More

FDA SIDE EFFECTS UPDATE: Zepbound for Obstructive Sleep Apnea, Ibrance And Blood Clots, Plus More

FDA side effect update, Depo Provera

FDA SIDE EFFECTS UPDATE: Depo Provera and Brain Tumors, Veozah Boxed Warning And More

Transforming U.S. Drug Policy, equitable healthcare

MedShadow Articles

Opinion: Transforming U.S. Drug Policy for Better Drug Safety

Suzanne B. Robotti

FDA Approves New Drug Veozah for Hot Flashes ... Is It Safe?

FDA Approves New Drug Veozah for Hot Flashes ... Is It Safe?

Medication Articles

How Safe is Veozah? The FDA-Approved Hot Flash Treatment

girl investigating the fda on her computer

MedShadow Articles

Inside the FDA Drug Development Process: The Limits of Clinical Trials in Preventing Side Effects

Daphne Berryhill

FDA SIDE EFFECTS UPDATE: GLP-1 Drugs And The Risk Of Serious Breathing Complications

MedShadow Articles

FDA Side Effects Update: GLP-1 Drugs and Breathing Risks

fda safety update, pills

MedShadow Articles

FDA Side Effects Update: Jylamvo, Limbitrol, Liptruzet, and More

What to Know About the Right to Try Law in 2024

What to Know About the Right to Try Law in 2024

MedShadow Articles

Choices For The Terminally Ill: FDA’S Expanded Access Program Or Right To Try Act?

Jessica DiGiacinto

Open Letter to the FDA: You’re Protecting the Wrong People

Su Calls on the FDA to Release the Names of Drugs Approved Using Fraudulent Data

Open Letter to the FDA: You’re Protecting the Wrong People

Suzanne B. Robotti

Heart Failure Drug Rejected, Rejected Again, Then Approved, What’s Up?

MedShadow Articles

Heart Failure Drug Rejected, Rejected Again, Then Approved, What’s Up?

FDA

Judge vs. FDA: Drug Safety and Effectiveness

Suzanne B. Robotti

FDA Advisory Committee and FDA Drug Approval

Advice for FDA Drug Approvals

Suzanne B. Robotti

Drug Recalls

Drug Recalls

Tianeptine Dangerous, FDA Says

Antidepressants and Anxiety Meds

Tianeptine Dangerous, FDA Says

Family Dollar Recall

Family Dollar Products Recalled Due to Contamination

FDA’s Black Box Warning for Xeljanz Leaves Patients, Doctors Scratching Their Heads

FDA’s Black Box Warning for Xeljanz Leaves Patients, Doctors Scratching Their Heads

Part 2: The FDA Cracks Down On Stem Cell Therapy

Regenerative Medicine Series

Part 2: The FDA Cracks Down On Stem Cell Therapy

Makena: Say “No!” To Meds That Don’t Work

Makena: Say “No!” To Meds That Don’t Work

Suzanne B. Robotti

Why The FDA Withdrew Emergency Use Status For Hydroxychloroquine

Why The FDA Withdrew Emergency Use Status For Hydroxychloroquine

Load More